KADIAN 20 mg (Morphine sulfate extended-release 20 mg)

Pill imprint KADIAN 20 mg has been identified as Morphine sulfate extended-release 20 mg.

Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 20 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.

See also related documents.

Images for KADIAN 20 mg (Morphine sulfate extended-release 20 mg)

Morphine sulfate extended-release 20 mg KADIAN 20 mg
Morphine sulfate extended-release 20 mg KADIAN 20 mg
Morphine sulfate extended-release
Imprint:
KADIAN
20 mg
Strength:
20 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Narcotic analgesics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Actavis

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)